MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential

KC Chiang, SF Kuo, CH Chen, S Ng, SF Lin, CN Yeh… - Cancer letters, 2015 - Elsevier
The survival rate of anaplastic thyroid cancer (ATC) is still very poor due to its fast growth
and high metastatic potential. Currently, no effective treatment is available. The active form …

Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China

C Sun, Q Li, Z Hu, J He, C Li, G Li, X Tao, A Yang - PloS one, 2013 - journals.plos.org
Background Anaplastic thyroid carcinoma (ATC), a highly aggressive malignancy, has a
poor prognosis, and the consensus on the most effective treatment is needed. Methods …

Long-term results of radiotherapy in anaplastic thyroid cancer

AK Dumke, T Pelz, D Vordermark - Radiation Oncology, 2014 - Springer
Background Anaplastic thyroid cancer (ATC) is an aggressive malignant tumour with a poor
prognosis. The median overall survival is described in the literature to be just 6 months …

Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups

DE Heron, S Karimpour… - American journal of clinical …, 2002 - journals.lww.com
Anaplastic thyroid carcinoma (ATC) is a highly aggressive neoplasm with a poor prognosis.
Curative management of these tumors has been difficult secondary to delayed diagnosis …

Recurrence and survival after gross total removal of resectable undifferentiated or poorly differentiated thyroid carcinoma

DY Lee, JK Won, HS Choi, DJ Park, KC Jung… - Thyroid, 2016 - liebertpub.com
Background: This study aimed to evaluate the recurrence and survival after initial curative-
intent surgery of resectable anaplastic thyroid cancer (ATC) and poorly differentiated thyroid …

The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer

N Denaro, CL Nigro, EG Russi… - OncoTargets and …, 2013 - Taylor & Francis
Anaplastic thyroid cancer represents 1%–2% of thyroid cancers. For its aggressiveness, it is
considered a systemic disease at the time of diagnosis. Surgery remains the cornerstone of …

Anaplastic thyroid cancer in British Columbia 1985–1999: a population-based study

V Goutsouliak, JH Hay - Clinical Oncology, 2005 - Elsevier
AIMS: To review the outcome of patients diagnosed with anaplastic thyroid carcinoma in
British Columbia between January 1985 and December 1999. MATERIALS AND …

Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer

JA Sosa, J Balkissoon, S Lu, P Langecker, R Elisei… - Surgery, 2012 - Elsevier
Background Anaplastic thyroid cancer (ATC) is an aggressive neoplasm for which a paucity
of data exist about the relative role of operative procedures in disease management …

Anaplastic thyroid cancer evolved from papillary carcinoma: Demonstration of anaplastic transformation by means of the inter–simple sequence repeat polymerase …

SM Wiseman, TR Loree, WL Hicks… - … –Head & Neck …, 2003 - jamanetwork.com
Background In thyroid tumors, the coexistence of well-and poorly differentiated tumor types
has led to the hypothesis that poorly differentiated thyroid tumors develop from well …

Surgical options in undifferentiated thyroid carcinoma

BHH Lang, CY Lo - World journal of surgery, 2007 - Springer
Undifferentiated or anaplastic carcinoma is an uncommon histologic type of thyroid cancer. It
is one of the most aggressive malignancies associated with a poor prognosis. Most patients …